, 2010 应用膜技术来浓缩和分离蛋白质已经广泛应用于生物技术产业中，而蛋白质的分离效率偏低以及浓差极化和膜污染造成的通量下降是制约其在工业上广泛应用的技术瓶颈之一。采用外加电场与错流膜过程相结合的方法由于其独有的优点，得到了国内外研究人员的广泛关注，但目前还存在着机理研究不够等诸多问题。本文重点从提高电场强化蛋白质超滤过程的效率，提高蛋白质分离效率，以及该过程在真实体系的应用研究等几个方面进行了研究。 论文首先采用牛血清白蛋白（BSA）作为模型蛋白质，考察了电场强化超滤过程的基本参数对单组分蛋白质超滤过程的影响 ...
宋伟杰
core
[Silybin inhibits fibrosis after glaucoma filtration surgery in rabbits by promoting fibroblast autophagy]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoZhang Y +5 more
europepmc +1 more source
Study on Concentration Polarization and Membrane Fouling during Ultrafiltration Processes
, 2009 超滤技术由于其高效快速、操作简便、低能耗、无污染等优点，近年来在多个领域展现出广泛的应用价值。浓差极化和膜污染是超滤过程中固有的客观现象，而浓差极化又是诱导膜污染的主要成因之一，两者会导致膜通量下降，清洗周期缩短，使用寿命降低等问题，制约了膜技术的广泛应用。因而需要对超滤过程中浓差极化和膜污染进行充分的研究，以期为控制和强化超滤过程，探寻膜污染控制新思路和新方法提供借鉴。 基于上述目的，本文尝试选择适当的模型和体系，建立起浓差极化和膜污染性质与操作条件之间的关联 ...
谢梓峰
core
[Lactate induces gastric mucosal injury by promoting M1 polarization of macrophages <i>via</i> the cardio-gastric axis]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoYang Y, Jia Y, Yin G, Li S, Yang P.
europepmc +1 more source
[Mechanism of <i>Tongxie Yaofang</i> for reducing 5-HT-induced oxidative stress injury in BRL 3A cells: the mediating role of the SREBP-1/CD1 pathway]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoSong M +5 more
europepmc +1 more source
[A new method for extracting adult mouse cardiac fibroblasts more efficiently and stably]. [PDF]
Beijing Da Xue Xue Bao Yi Xue BanMa X +10 more
europepmc +1 more source
[Establishment of an Epstein-Barr virus infection model using human nasal organoids]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoWei J +5 more
europepmc +1 more source
[Screening of the anti-<i>Malassezia furfur</i> active fraction from <i>Rosa chinensis</i> Jacq. and study on its mechanism against seborrheic dermatitis]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanGuo Z, Xi X, Zhong X, Qiu F, Huang Z.
europepmc +1 more source
[In vitro and in vivo antibacterial effects of the mitochondrial antioxidant Visomitin against <i>Enterococcus</i>]. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanYang Q, Wu Y, Wu R, She P.
europepmc +1 more source
[Research progress on the pathogenesis and clinical treatment of cirrhotic cardiomyopathy]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang KY, Liu L.
europepmc +1 more source